(MedPage Today) — Prescriptions for GLP-1 receptor agonists increased among postpartum women once semaglutide (Ozempic, Wegovy) was approved for weight loss, a Danish epidemiological study found.
In the first quarter of 2018, there were less…
Source link : https://www.medpagetoday.com/obgyn/pregnancy/118676
Author :
Publish date : 2025-11-24 19:15:00
Copyright for syndicated content belongs to the linked Source.
